Neurophysiological, biomolecular and psychological predictors of response to Erenumab in chronic migraine

被引：0
|
作者：
Fiamingo, G. [1 ]
De Icco, R. [1 ]
Greco, R. [2 ]
Zanaboni, A. M. [3 ]
Bottiroli, S. [4 ]
Guaschino, E. [5 ]
Allena, M. [5 ]
Grillo, V. [5 ]
Tassorelli, C. [1 ]
Sancess, G. [5 ]
机构：
[1] Univ Pavia, IRCCS Mondino Fdn, Headache Sci Ctr, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS Mondino Fdn, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[3] Univ Pavia, IRCCS Mondino Fdn, Dept Brain & Behav Sci, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[4] Giustino Fortunato Univ, IRCCS Mondino Fdn, Fac Law, Headache Sci Ctr, Pavia, Italy
[5] IRCCS Mondino Fdn, Headache Sci Ctr, Pavia, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1153
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [31] Temporal Response Patterns to Erenumab in Patients with Episodic Migraine
    McAllister, P.
    Turner, I. M.
    Reuter, U.
    Vargas, B. B.
    Scanlon, J., V
    Klatt, J.
    Richards, S.
    Chou, D. E.
    Lima, G. Paiva Da Silva
    HEADACHE, 2019, 59 : 106 - 106
  • [32] Temporal response patterns to erenumab in patients with episodic migraine
    McAllister, Peter
    Turner, Ira M.
    Reuter, Uwe
    Vargas, Bert B.
    Scanlon, James V.
    Klatt, Jan
    Richards, Sharon
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2019, 39 : 216 - 217
  • [33] Timing and durability of response to erenumab in patients with episodic migraine
    McAllister, Peter J.
    Turner, Ira
    Reuter, Uwe
    Wang, Andrea
    Scanlon, James
    Klatt, Jan
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    HEADACHE, 2021, 61 (10): : 1553 - 1561
  • [34] The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
    Brandes, Jan Lewis
    Diener, Hans-Christoph
    Dolezil, David
    Freeman, Marshall C.
    McAllister, Peter J.
    Winner, Paul
    Klatt, Jan
    Cheng, Sunfa
    Zhang, Feng
    Wen, Shihua
    Ritter, Shannon
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2020, 40 (01) : 28 - 38
  • [35] Erenumab in chronic migraine: a conventional scheme versus erenumab plus short dechronification - Pilot data
    Nicolodi, Maria
    Pinnaro, Maria Stella
    Italy, Vanessa S.
    Sandoval
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 412 - 413
  • [36] Psychological and neurophysiological features of patients suffering from migraine
    Petrov, K. M.
    Glozman, J. M.
    Korabelnikova, E. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 136 - 137
  • [37] NEUROPHYSIOLOGICAL AND PSYCHOLOGICAL PREDICTORS OF GENETIC RISK FOR SCHIZOPHRENIA
    TRUBNIKOV, V
    UVAROVA, L
    ALFIMOVA, M
    ORLOVA, V
    OZEROVA, N
    ABROSIMOV, N
    BEHAVIOR GENETICS, 1993, 23 (05) : 455 - 459
  • [38] Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
    Manickam, A. H.
    Buture, A.
    Tomkins, E.
    Ruttledge, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 166 - 166
  • [39] Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
    Manickam, A. H.
    Buture, A.
    Tomkins, E.
    Ruttledge, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 112 - 112
  • [40] Erenumab during pregnancy: a case report in a patient with chronic migraine
    Luisa Fofi
    Gabriella Egeo
    Cinzia Aurilia
    Piero Barbanti
    Neurological Sciences, 2021, 42 : 2145 - 2146
12345